Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/45712, first published .
Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients (DOPPIO): Protocol for a Prospective Multicenter Study

Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients (DOPPIO): Protocol for a Prospective Multicenter Study

Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients (DOPPIO): Protocol for a Prospective Multicenter Study

Sibylle Mellinghoff   1, 2, 3 * , MD ;   Gero von Gersdorff   4, 5 * , MD ;   Caroline Bruns   1, 2, 6 , PhD ;   Kerstin Albus   1, 2, 6 , PhD ;   Vassiliki Dimitriou   1, 2, 6 , PhD ;   Angela Steinbach   1, 2, 6 , PhD ;   Mathias Schaller   4 , PhD ;   Jörg Janne Vehreschild   1 , MD ;   Oliver A Cornely   1, 2, 6, 7 , MD ;   Blasius Janusch Liss   8, 9 , MD

1 Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf and Excellence Centre for Medical Mycology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

2 German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany

3 Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany

4 Faculty of Medicine and University Hospital Cologne, Department II of Internal Medicine – QiN-group, University of Cologne, Cologne, Germany

5 Kuratorium fuer Haemaodialyse (KfH)-Board of Trustees for Dialysis and Kidney Transplantation, Neu-Isenburg, Germany

6 Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

7 Clinical Trials Centre Cologne (ZKS Köln), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

8 Department I of Internal Medicine, Helios University Hospital Wuppertal, Wuppertal, Germany

9 School of Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany

*these authors contributed equally

Corresponding Author:

  • Sibylle Mellinghoff, MD
  • Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf and Excellence Centre for Medical Mycology
  • Department I of Internal Medicine
  • Faculty of Medicine and University Hospital Cologne, University of Cologne
  • Kerpener Str 62
  • Cologne, 50937
  • Germany
  • Phone: 49 221478 ext 85523
  • Email: sibylle.mellinghoff@uk-koeln.de